Literature DB >> 19254476

Cell death mechanisms induced by cytotoxic lymphocytes.

L Chávez-Galán1, M C Arenas-Del Angel, E Zenteno, R Chávez, R Lascurain.   

Abstract

One of the functions of the immune system is to recognize and destroy abnormal or infected cells to maintain homeostasis. This is accomplished by cytotoxic lymphocytes. Cytotoxicity is a highly organized multifactor process. Here, we reviewed the apoptosis pathways induced by the two main cytotoxic lymphocyte subsets, natural killer (NK) cells and CD8+ T cells. In base to recent experimental evidence, we reviewed NK receptors involved in recognition of target-cell, as well as lytic molecules such as perforin, granzymes-A and -B, and granulysin. In addition, we reviewed the Fas-FasL intercellular linkage mediated pathway, and briefly the cross-linking of tumor necrosis factor (TNF) and TNF receptor pathway. We discussed three models of possible molecular interaction between lytic molecules from effector cytotoxic cells and target-cell membrane to induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254476      PMCID: PMC4002546          DOI: 10.1038/cmi.2009.3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  92 in total

Review 1.  Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

Authors:  Richard Wu; Marie-Andrée Forget; Jessica Chacon; Chantale Bernatchez; Cara Haymaker; Jie Qing Chen; Patrick Hwu; Laszlo G Radvanyi
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

2.  Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized mice.

Authors:  Chelsea M Black; Todd D Armstrong; Elizabeth M Jaffee
Journal:  Cancer Immunol Res       Date:  2014-01-17       Impact factor: 11.151

3.  Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells.

Authors:  Birte Pantenburg; Alejandro Castellanos-Gonzalez; Sara M Dann; Rhykka L Connelly; Dorothy E Lewis; Honorine D Ward; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

4.  Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.

Authors:  Adam R Hersperger; Jeffrey N Martin; Lucy Y Shin; Prameet M Sheth; Colin M Kovacs; Gabriela L Cosma; George Makedonas; Florencia Pereyra; Bruce D Walker; Rupert Kaul; Steven G Deeks; Michael R Betts
Journal:  Blood       Date:  2011-02-02       Impact factor: 22.113

5.  Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression.

Authors:  Chong-Sheng Chen; Joshua C Doloff; David J Waxman
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 6.  Cell death and autophagy in tuberculosis.

Authors:  Andrew H Moraco; Hardy Kornfeld
Journal:  Semin Immunol       Date:  2014-10-17       Impact factor: 11.130

7.  Hormonal regulation of NK cell cytotoxic activity.

Authors:  S V Shirshev; I V Nekrasova; O L Gorbunova; E G Orlova
Journal:  Dokl Biol Sci       Date:  2017-04-21

Review 8.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Fas gene variants in childhood acute lymphoblastic leukemia and association with prognosis.

Authors:  Behnaz Valibeigi; Zahra Amirghofran; Hossein Golmoghaddam; Reza Hajihosseini; Fatemeh M Kamazani
Journal:  Pathol Oncol Res       Date:  2013-11-12       Impact factor: 3.201

10.  Ovine CD16+/CD14- blood lymphocytes present all the major characteristics of natural killer cells.

Authors:  Jamila Elhmouzi-Younes; Preben Boysen; Daniela Pende; Anne K Storset; Yves Le Vern; Fabrice Laurent; Françoise Drouet
Journal:  Vet Res       Date:  2009-09-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.